In silico approach towards lipase mediated chemoenzymatic synthesis of (S)-ranolazine, as an anti-anginal drug

Chemoenzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker

(2016) Saptarshi Ghosh et al.   CHIRALITY

Lipase-catalyzed green synthesis of enantiopure atenolol

(2015) Bharat Prasad Dwivedee et al.   RSC Advances

“All water chemistry” for a concise total synthesis of the novel class anti-anginal drug (RS), (R), and (S)-ranolazine

(2013) Damodara N. Kommi et al.   GREEN CHEMISTRY

An efficient protocol for regioselective ring opening of epoxides using sulfated tungstate: application in synthesis of active pharmaceutical ingredients atenolol, propranolol and ranolazine

(2013) Sagar P. Pathare et al.   TETRAHEDRON LETTERS

A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond

(2013) Neelam Gurung et al.   Biomed Research International

Improved Process for Ranolazine: An Antianginal Agent

(2012) Sampath Aalla et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Role of ranolazine in angina, heart failure, arrhythmias, and diabetes

(2011) Samuel Sossalla et al.   PHARMACOLOGY & THERAPEUTICS

Rational assignment of key motifs for function guides in silico enzyme identification

(2010) Matthias Höhne et al.   Nature Chemical Biology

Molecular modeling of substrate selectivity of Candida antarctica lipase B and Candida rugosa lipase towards c9, t11- and t10, c12-conjugated linoleic acid

(2008) Wencheng Li et al.   JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC